T. Rowe Price Associates’s Pacira BioSciences PCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.15M Buy
47,910
+2,916
+6% +$69.8K ﹤0.01% 1927
2025
Q1
$1.12M Buy
44,994
+3,688
+9% +$91.7K ﹤0.01% 1898
2024
Q4
$779K Sell
41,306
-9,409
-19% -$177K ﹤0.01% 2071
2024
Q3
$764K Sell
50,715
-198,429
-80% -$2.99M ﹤0.01% 2075
2024
Q2
$7.13M Sell
249,144
-82,876
-25% -$2.37M ﹤0.01% 1162
2024
Q1
$9.7M Sell
332,020
-71,733
-18% -$2.1M ﹤0.01% 1115
2023
Q4
$13.6M Sell
403,753
-5,236
-1% -$177K ﹤0.01% 1035
2023
Q3
$12.5M Buy
408,989
+1,447
+0.4% +$44.4K ﹤0.01% 1021
2023
Q2
$16.3M Buy
407,542
+1,256
+0.3% +$50.3K ﹤0.01% 985
2023
Q1
$16.6M Buy
406,286
+2,164
+0.5% +$88.3K ﹤0.01% 967
2022
Q4
$15.6M Buy
404,122
+11,048
+3% +$427K ﹤0.01% 973
2022
Q3
$20.9M Buy
393,074
+4,384
+1% +$233K ﹤0.01% 885
2022
Q2
$22.7M Buy
388,690
+10,925
+3% +$637K ﹤0.01% 1130
2022
Q1
$28.8M Buy
377,765
+2,304
+0.6% +$176K ﹤0.01% 1135
2021
Q4
$22.6M Buy
375,461
+3,873
+1% +$233K ﹤0.01% 1258
2021
Q3
$20.8M Sell
371,588
-2,064
-0.6% -$116K ﹤0.01% 1287
2021
Q2
$22.7M Buy
373,652
+9,689
+3% +$588K ﹤0.01% 1270
2021
Q1
$25.5M Sell
363,963
-5,326
-1% -$373K ﹤0.01% 1213
2020
Q4
$22.1M Sell
369,289
-2,932
-0.8% -$175K ﹤0.01% 1203
2020
Q3
$22.4M Buy
372,221
+514
+0.1% +$30.9K ﹤0.01% 1123
2020
Q2
$19.5M Sell
371,707
-45,362
-11% -$2.38M ﹤0.01% 1151
2020
Q1
$14M Sell
417,069
-2,052
-0.5% -$68.8K ﹤0.01% 1166
2019
Q4
$19M Buy
419,121
+9,801
+2% +$444K ﹤0.01% 1200
2019
Q3
$15.6M Buy
409,320
+4,947
+1% +$188K ﹤0.01% 1217
2019
Q2
$17.6M Buy
404,373
+37,443
+10% +$1.63M ﹤0.01% 1210
2019
Q1
$14M Sell
366,930
-717,082
-66% -$27.3M ﹤0.01% 1262
2018
Q4
$46.6M Sell
1,084,012
-200,751
-16% -$8.64M 0.01% 845
2018
Q3
$63.1M Sell
1,284,763
-379,791
-23% -$18.7M 0.01% 823
2018
Q2
$53.3M Sell
1,664,554
-141,714
-8% -$4.54M 0.01% 873
2018
Q1
$56.3M Sell
1,806,268
-10,798
-0.6% -$336K 0.01% 825
2017
Q4
$82.9M Buy
1,817,066
+27,014
+2% +$1.23M 0.01% 702
2017
Q3
$67.2M Sell
1,790,052
-266,740
-13% -$10M 0.01% 740
2017
Q2
$98.1M Sell
2,056,792
-383,488
-16% -$18.3M 0.02% 611
2017
Q1
$111M Sell
2,440,280
-139,221
-5% -$6.35M 0.02% 570
2016
Q4
$83.3M Sell
2,579,501
-798,090
-24% -$25.8M 0.02% 654
2016
Q3
$116M Sell
3,377,591
-1,054,152
-24% -$36.1M 0.02% 540
2016
Q2
$149M Buy
4,431,743
+298,369
+7% +$10.1M 0.03% 471
2016
Q1
$219M Buy
4,133,374
+90,079
+2% +$4.77M 0.05% 378
2015
Q4
$310M Buy
4,043,295
+126,925
+3% +$9.75M 0.07% 303
2015
Q3
$161M Buy
3,916,370
+50,543
+1% +$2.08M 0.04% 457
2015
Q2
$273M Sell
3,865,827
-450,394
-10% -$31.9M 0.06% 367
2015
Q1
$383M Sell
4,316,221
-61,430
-1% -$5.46M 0.08% 289
2014
Q4
$388M Sell
4,377,651
-752,614
-15% -$66.7M 0.08% 282
2014
Q3
$497M Buy
5,130,265
+403,539
+9% +$39.1M 0.11% 222
2014
Q2
$434M Buy
4,726,726
+79,630
+2% +$7.31M 0.09% 255
2014
Q1
$325M Sell
4,647,096
-119,171
-3% -$8.34M 0.07% 316
2013
Q4
$274M Sell
4,766,267
-130,563
-3% -$7.51M 0.06% 355
2013
Q3
$235M Sell
4,896,830
-1,067,873
-18% -$51.4M 0.06% 367
2013
Q2
$173M Buy
+5,964,703
New +$173M 0.05% 427